Information was received from a consumer regarding a patient who was implanted with a neurostimulator for parkinson's disease and movement disorders.It was reported that 2-3 years after the device was implanted, the patient experienced a gradual return of tremors.Follow-up with the health care provider (hcp) indicated that the patient was seen on (b)(6) 2016.During it visit, it was reported that the ins reached elective replacement indicator (eri), and the patient was experiencing an action tremor in her right hand.The patient also experienced ataxic gait, more trouble eating, drinking, and tying her shoes; she dropped a plate and was upset.It was reported that the patient also suffered from a learning disorder, a lowered level of cognitive functioning, and unrelated cancer that was being treated with anastrozole.The patient was seen again on (b)(6) 2016 as her implantable neurostimulator (ins) reached end of service (eos) and was off; the device was replaced the following day.It was also stated that the patient experienced a shocking sensation followed by a worsening of tremors earlier in the week.A full system check showed no further problems that included normal impedances and the patient did not report any further episodes of discomfort.The hcp stated that the "shocking was likely the deep brain stimulation (dbs) turning off from the ins depletion".The following concomitant medications were reported: anastrozole, medroxy progesterone, mupirocin 2% external ointment, phenobarbital, pravastatin sodium, primidone, vitamin d tabs.
|